Aardvark Therapeutics, Inc.

CRL AI-extracted

ARD-101

Prader-Willi Syndrome

Date

TBD

FDA decision · Date TBD estimated

What's at stake An FDA complete response letter on ARD-101 for Prader-Willi Syndrome is in focus around Date TBD.

Primary source · SEC 8-K verified 14h ago

“the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on its investigational new drug application (IND) for ARD-101”